NOUVEAUTES THERAPEUTIQUESLESIEUR D; LESIEUR DEMARQUILLY I.1979; BULL. SOC. PHARM. LILLE; FRA; DA. 1979; VOL. 35; NO 4; PP. 195-215Article

HEXAMETHYLMELAMINE : A NEW DRUG WITH ACTIVITY IN SOLID TUMORSBLUM RH; LIVINGSTON RB; CARTER SK et al.1973; EUROP. J. CANCER; G.B.; DA. 1973; VOL. 9; NO 3; PP. 195-202; BIBL. 19REF.Serial Issue

CARBINOLAMINES AND RELATED STRUCTURES: POTENTIAL ALKYLATING METABOLITES OF CLINICALLY ACTIVE ANTICANCER DRUGSSOLOWAY AH; BRUMBAUCH RJ; WITIAK DT et al.1983; JOURNAL OF THEORETICAL BIOLOGY; ISSN 0022-5193; GBR; DA. 1983; VOL. 102; NO 3; PP. 361-373; BIBL. 2 P.Article

HEXAMETHYLMELAMINE AND PENTAMETHYLMELAMINE TISSUE DISTRIBUTION IN M5076/73A OVARIAN CANCER-BEARING MICEBROGGINI M; ROSSI C; COLOMBO T et al.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 1; PP. 127-133; BIBL. 16 REF.Article

HEXAMETHYLMELAMINE AND PREDNISONE IN THE TREATMENT OF REFRACTORY MULTIPLE MYELOMACOHEN HJ; BARTOLUCCI AA.1982; AM. J. CLIN. ONCOL.; ISSN 512273; USA; DA. 1982; VOL. 5; NO 1; PP. 21-27; BIBL. 15 REF.Article

DOXORUBICIN-HEXAMETHYLMELAMINE THERAPY OF SMALL CELL CARCINOMA OF THE LUNGDARA P; SCHULTZ MJ; SLATER LM et al.1981; CANCER; ISSN 0008-543X; USA; DA. 1981; VOL. 48; NO 9; PP. 1944-1946; BIBL. 22 REF.Article

THE ROLE OF HEXAMETHYLMELAMINE IN ADVANCED OVARIAN CARCINOMA TREATMENTWEISS RB.1981; GYNECOL. ONCOL.; ISSN 0090-8258; USA; DA. 1981; VOL. 12; NO 2; PART. 1; PP. 141-149; BIBL. 27 REF.Article

COMPARATIVE TRIAL OF TWO TENIPOSIDE-BASED COMBINATION CHEMOTHERAPY REGIMENS FOR THE TREATMENT OF ADVANCED MALIGNANT LYMPHOMAS = ESSAI COMPARANT DEUX PROTOCOLES DE CHIMIOTHERAPIE COMBINEE COMPRENANT DU V.M 26 DANS LE TRAITEMENT DES LYMPHOMES MALINS AVANCESO'CONNELL MJ; ANDERSON J; MERRILL JM et al.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 12; PP. 2021-2025; ABS. ENG; BIBL. 12 REF.; GRAPHArticle

HEXAMETHYLMELAMINE IN MUSTARD-RESISTANT OVARIAN ADENOCARCINOMAOMURA GA; GRECO FA; BIRCH R et al.1981; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1981; VOL. 65; NO 5-6; PP. 530-531; BIBL. 5 REF.Article

PHASE II STUDY OF CYCLOPHOSPHAMIDE AND HEXAMETHYLMELAMINE IN NON-OAT CELL BRONCHOGENIC CARCINOMAPISONI MB; LIBRETTI A; PIAZZA E et al.1981; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1981; VOL. 65; NO 7-8; PP. 731-732; BIBL. 4 REF.Article

Failure of hexamethylmelamine as salvage therapy in ovarian epithelial adenocarcinoma resistant to combination chemotherapy = Echec du traitement de rattrapage par hexaméthylmélamine des adénocarcinomes épithéliaux de l'ovaire résistant à la chimiothérapie combinéeSTEHMAN, F. B; EHRLICH, C. E; CALLANGAN, M. F et al.Gynecologic oncology (Print). 1984, Vol 17, Num 2, pp 189-195, issn 0090-8258Article

Hexamethylmelamine in adenocarcinoma of the pancreas and liver = L'hexaméthylmélamine dans le traitement des adénocarcinomes du pancréas et du foieOLDHAM, D. S; WAMPLER, G. L.Medical and pediatric oncology. 1983, Vol 11, Num 4, pp 297-298, issn 0098-1532Article

METABOLIC ACTIVATION OF HEXAMETHYLMELAMINE AND PENTAMETHYLMELAMINE BY LIVER MICROSOMAL PREPARATIONSAMES MM; SANDERS ME; TIEDE WS et al.1981; LIFE SCI. (1973); ISSN 0024-3205; GBR; DA. 1981; VOL. 29; NO 15; PP. 1591-1598; BIBL. 23 REF.Article

ORTHOSTATIC HYPOTENSION AS A COMPLICATION OF HEXAMETHYLMELAMINE ANTIDEPRESSANT INTERACTION = HYPOTENSION ORTHOSTATIQUE LIEE A L'INTERACTION DE L'HEXAMETHYLMELAMINE ET D'ANTIDEPRESSEURSBRUCKNER HW; SCHLEIFER SJ.1983; CANCER TREATMENT REPORTS; ISSN 0361-5960; USA; DA. 1983; VOL. 67; NO 5; PP. 516; BIBL. 5 REF.Article

HEXAMETHYLMELAMINE CHEMOTHERAPY FOR DISSEMINATED ENDOMETRIAL CANCERSESKI JC; EDWARDS CL; COPELAND LJ et al.1981; OBSTET. GYNECOL. (N.Y., 1953); ISSN 0029-7844; USA; DA. 1981; VOL. 58; NO 3; PP. 361-363; BIBL. 9 REF.Article

PHASE II STUDY OF HEXAMETHYLMELAMINE FOR DISSEMINATED PROSTATIC CARCINOMADRELICHMAN A; BROWNLEE R; AL SARRAF M et al.1981; CANCER CLIN. TRIALS; ISSN 0190-1206; USA; DA. 1981; VOL. 4; NO 3; PP. 309-312; BIBL. 13 REF.Article

Combination chemotherapy and immune capacity in advanced ovarian carcinoma = Polychimiothérapie et capacités immunitaires dans les carcinomes ovariens avancésTEN BERGE, R. J. M; SCHELLEKENS, P. T. A; HAMERLYNCK, J. V. T. H et al.European journal of cancer & clinical oncology. 1984, Vol 20, Num 1, pp 91-98, issn 0277-5379Article

Pancreatic beta cell vacuolation in rats after oral administration of hexamethylmelamineMOLELLO, J. A; BARNARD, S. D; THOMPSON, D. J et al.Toxicology and applied pharmacology. 1984, Vol 72, Num 2, pp 255-261, issn 0041-008XArticle

ROLE OF N-METHYLOLPENTAMETHYLMELAMINE IN THE METABOLIC ACTIVATION OF HEXAMETHYLMELAMINE = ROLE DE LA N-METHYLOLPENTAMETHYLMELAMINE DANS L'ACTIVATION METABOLIQUE DE L'HEXAMETHYLMELAMINEAMES MM; SANDERS ME; TIEDE WS et al.1983; CANCER RESEARCH; ISSN 0008-5472; USA; DA. 1983; VOL. 43; NO 2; PP. 500-504; ABS. ENG; BIBL. 34 REF.; GRAPH, FIGArticle

HEXAMETHYLMELAMINE AS A SINGLE AGENT IN THE TREATMENT OF SMALL-CELL CARCINOMA OF THE LUNGGOLDSWEIG HG; EDGERTON F; REDDEN CS et al.1982; AM. J. CLIN. ONCOL.; ISSN 512273; USA; DA. 1982; VOL. 5; NO 3; PP. 267-272; BIBL. 19 REF.Article

HEXAMETHYLMELAMINE DISTRIBUTION IN PATIENTS WITH PATIENTS WITH OVARIAN AND OTHER PELVIC CANCERSD'INCALCI M; FARINA P; SESSA C et al.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 2; PP. 231-235; BIBL. 19 REF.Article

CIS-PLATINUM-HEXAMETHYLMELAMINE THERAPY OF ADVANCED OVARIAN CANCERLOPEZ JA; KRIKORIAN JG; DIAS SF et al.1981; GYNECOL. ONCOL.; ISSN 0090-8258; USA; DA. 1981; VOL. 11; NO 1; PP. 64-67; BIBL. 6 REF.Article

TIME DEPENDENCE OF THE IN VITRO CYTOTOXICITY OF HEXAMETHYLMELAMINE AND ITS METABOLITESD'INCALCI M; ERBA E; BALCONI G et al.1980; BRIT. J. CANCER; GBR; DA. 1980; VOL. 41; NO 4; PP. 630-635; BIBL. 23 REF.Article

Changes in serum copper and zinc during treatment with anticancer drugs interfering with pyridoxal phosphateSLAVIK, M; NARASIMHAN, T. R; RILEY, C et al.Advances in experimental medicine and biology. 1989, Vol 258, pp 235-242, issn 0065-2598, 8 p.Conference Paper

Hexamethylmelamine aerosols prepared in an evaporation-condensation generatorGONDA, I; AHMED FARID ABD EL KHALIK; BRITTEN, A. Z et al.International journal of pharmaceutics. 1985, Vol 27, Num 2-3, pp 255-265, issn 0378-5173Article